Prophylactic nipple-sparing mastectomy with immediate breast reconstruction: results of a French prospective trial.


Journal

The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553

Informations de publication

Date de publication:
05 04 2021
Historique:
received: 24 03 2020
accepted: 14 10 2020
pubmed: 2 4 2021
medline: 11 8 2021
entrez: 1 4 2021
Statut: ppublish

Résumé

Nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) is used increasingly when performing a prophylactic mastectomy. Few prospective studies have reported on complication rates. This complementary trial to the French prospective multicentre MAPAM trial aimed to evaluate the nipple-areola complex (NAC) necrosis rate in prophylactic NSM with IBR. Patient characteristics and surgical data were recorded. Morbidity after prophylactic NSM with a focus on NAC necrosis was analysed. Among 59 women undergoing prophylactic NSM, 19 (32 per cent) of the incisions were partly on the NAC. Reconstructions were performed with 46 definitive implants and 13 expanders. The crude rate of postoperative complications was 25 per cent (15 patients). Complete NAC necrosis was reported in two women (3 per cent) and partial or total necrosis in nine (15 per cent). No NAC resection was necessary. Median BMI was lower in women with total or partial NAC necrosis compared with the others (20.0 versus 21.3 kg/m2 respectively; P = 0.034). Results of this prospective study confirm that prophylactic NSM with IBR is associated with a low risk of total NAC necrosis.

Sections du résumé

BACKGROUND
Nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR) is used increasingly when performing a prophylactic mastectomy. Few prospective studies have reported on complication rates. This complementary trial to the French prospective multicentre MAPAM trial aimed to evaluate the nipple-areola complex (NAC) necrosis rate in prophylactic NSM with IBR.
METHODS
Patient characteristics and surgical data were recorded. Morbidity after prophylactic NSM with a focus on NAC necrosis was analysed.
RESULTS
Among 59 women undergoing prophylactic NSM, 19 (32 per cent) of the incisions were partly on the NAC. Reconstructions were performed with 46 definitive implants and 13 expanders. The crude rate of postoperative complications was 25 per cent (15 patients). Complete NAC necrosis was reported in two women (3 per cent) and partial or total necrosis in nine (15 per cent). No NAC resection was necessary. Median BMI was lower in women with total or partial NAC necrosis compared with the others (20.0 versus 21.3 kg/m2 respectively; P = 0.034).
CONCLUSION
Results of this prospective study confirm that prophylactic NSM with IBR is associated with a low risk of total NAC necrosis.

Identifiants

pubmed: 33793719
pii: 6120369
doi: 10.1093/bjs/znaa082
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

296-301

Investigateurs

C Bouteille (C)
W Gertych (W)
M Baron (M)
N Leymarie (N)
P Bertrand (P)

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

G Houvenaeghel (G)

Department of Surgical Oncology, Paoli Calmettes Institute and Centre de Recherche en Cancerérologie de Marseille (CRCM), Aix-Marseille University, Marseille, France.

M Cohen (M)

Department of Surgical Oncology, Paoli Calmettes Institute, Marseille, France.

M A Dammacco (MA)

Department of Surgical Oncology, Centre Léon Bérard, Lyon, France.

F D'Halluin (F)

Surgery Department, L'Etablissement Rennais du Sein, Centre Hospitalier Privé St Grégoire, St Grégoire, France.

C Regis (C)

Department of Surgical Oncology, Centre Oscar Lambret, Lille, France.

M Gutowski (M)

Department of Surgical Oncology, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France.

O Acker (O)

Surgery Department, Pôle Santé Léonard de Vinci, Chambray les Tours, France.

M Fournier (M)

Department of Surgical Oncology, Institut Bergonie, Bordeaux, France.

M Bannier (M)

Department of Surgical Oncology, Paoli Calmettes Institute, Marseille, France.

A Lusque (A)

Department of Biostatistics, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.

E Jouve (E)

Department of Surgical Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH